Vasoactive intestinal peptide and pituitary adenylate cyclase activating polypeptide as serum biomarkers in a sample of Egyptian multiple sclerosis patients

Abstract Background Multiple sclerosis (MS) is the most common immune-mediated inflammatory demyelinating disease of the central nervous system. Axonal injury is also a prominent pathologic feature, especially in the later stages. Our aim is to determine serum levels of vasoactive intestinal peptide...

Cijeli opis

Bibliografski detalji

Glavni autori:	Ebtesam Mohamed Fahmy, Amany Mahmoud Rabah, Sahar Abd El-Atty Sharaf, Sarah Heneidy, Nora Mahmoud Selim, Mostafa Yahya Garadah, Shaimaa Shaheen Mohammed
Format:	Artigo
Jezik:	Inglês
Izdano:	SpringerOpen 2025-11-01
Serija:	The Egyptian Journal of Neurology, Psychiatry and Neurosurgery
Teme:	Multiple sclerosis Vasoactive intestinal peptide Pituitary adenylate cyclase activating polypeptide
Online pristup:	https://doi.org/10.1186/s41983-025-01043-7
Oznake:	Dodaj oznaku Bez oznaka, Budi prvi tko označuje ovaj zapis!